Drug Costs

NIH Study Links Rare Disease to Higher Healthcare Costs

October 26, 2021 - In a retrospective study led by the National Institutes of Health’s National Center for Advancing Translation Sciences (NCATS), researchers provide evidence that individuals with rare diseases face significantly higher healthcare costs. “There needs to be greater public awareness of the large and growing medical footprint of rare...

Read More


More Articles

Genetic Testing Could Help Clinicians Prescribe Blood Thinners

by Jessica Kent

Genetic testing can help providers identify the appropriate anti-platelet drugs for patients, leading to enhanced efficacy and fewer side effects, according to a study published in JACC: Cardiovascular...

Precision Medicine Informs Cost-Effective Heart Disease Treatments

by Jessica Kent

Using precision medicine approaches to tailor heart disease therapies could lead to more cost-effective treatments and improved patient outcomes, according to a study led by researchers at the...

New Initiative Uses Artificial Intelligence for Vaccine Development

by Jessica Kent

The Harvard T.H. Chan School of Public Health and the Human Vaccines Project have announced the Human Immunomics Initiative, a joint effort that will use artificial intelligence models to accelerate...

Recent Articles